Clarity Pharmaceuticals Ltd (ASX:CU6)
2.980
-0.200 (-6.29%)
Aug 29, 2025, 4:10 PM AEST
Clarity Pharmaceuticals Revenue
In the fiscal year ending June 30, 2025, Clarity Pharmaceuticals had annual revenue of 9.46M AUD, down -17.76%. Clarity Pharmaceuticals had revenue of 4.77M in the half year ending June 30, 2025, with 17.37% growth.
Revenue
9.46M
Revenue Growth
-17.76%
P/S Ratio
117.13
Revenue / Employee
137.14K
Employees
50
Market Cap
1.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 9.46M | -2.04M | -17.76% |
Jun 30, 2024 | 11.51M | 1.71M | 17.41% |
Jun 30, 2023 | 9.80M | 3.34M | 51.74% |
Jun 30, 2022 | 6.46M | 3.26M | 102.06% |
Jun 30, 2021 | 3.20M | 407.65K | 14.62% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 23.73B |
Pro Medicus | 212.98M |
Cochlear | 2.34B |
Sonic Healthcare | 9.65B |
Ramsay Health Care | 17.12B |
Telix Pharmaceuticals | 1.01B |
Ansell | 3.06B |
Mesoblast | 9.16M |
Clarity Pharmaceuticals News
- 24 days ago - Greatland Resources, Clarity Pharma headline huge ASX 200 rebalance - The Australian Financial Review
- 4 weeks ago - Clarity Pharmaceuticals readies mega capital raising - The Australian Financial Review
- 9 months ago - Indoco Remedies stock surges 8% on partnership with Clarity Pharma in the UK - Business Upturn
- 9 months ago - Indoco Remedies partners with Clarity Pharma to strengthen UK presence - Business Upturn
- 11 months ago - Rising Shares at Clarity Pharmaceuticals as it Launches Second Phase III Trial and Promotes Michelle Parker to CEO - CEOWORLD magazine
- 1 year ago - Three ASX companies jockeying to be the next biotech winners - The Australian Financial Review